Fakhri Mahdi

3.9k total citations
93 papers, 3.1k citations indexed

About

Fakhri Mahdi is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Fakhri Mahdi has authored 93 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Genetics and 22 papers in Hematology. Recurrent topics in Fakhri Mahdi's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (28 papers), Blood Coagulation and Thrombosis Mechanisms (21 papers) and HIV Research and Treatment (12 papers). Fakhri Mahdi is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (28 papers), Blood Coagulation and Thrombosis Mechanisms (21 papers) and HIV Research and Treatment (12 papers). Fakhri Mahdi collaborates with scholars based in United States, China and Brazil. Fakhri Mahdi's co-authors include Alvin H. Schmaier, Zia Shariat‐Madar, Keith Garlid, Gene L. Bidwell, Carlos D. Figueroa, Petr Pauček, G. D. Mironova, Gebretateos Woldegiorgis, Andrew D. Beavis and Dale G. Nagle and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Fakhri Mahdi

92 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fakhri Mahdi United States 33 1000 944 613 550 335 93 3.1k
Michael Holinstat United States 39 1.6k 1.6× 285 0.3× 1.1k 1.8× 456 0.8× 163 0.5× 116 4.5k
Carol Dangelmaier United States 33 1.0k 1.0× 404 0.4× 1.4k 2.3× 448 0.8× 130 0.4× 89 3.1k
Noboru Fukuda Japan 36 2.1k 2.1× 698 0.7× 169 0.3× 400 0.7× 120 0.4× 234 4.4k
Vijay K. Kalra United States 29 1.3k 1.3× 526 0.6× 340 0.6× 348 0.6× 128 0.4× 71 2.9k
Osamu Nakajima Japan 29 1.9k 1.9× 200 0.2× 253 0.4× 450 0.8× 181 0.5× 128 3.4k
S Lévy-Toledano France 38 1.5k 1.5× 359 0.4× 1.6k 2.5× 318 0.6× 119 0.4× 135 4.1k
Ingeborg Hers United Kingdom 28 1.9k 1.9× 241 0.3× 838 1.4× 338 0.6× 150 0.4× 65 3.6k
Hanna Mandel Israel 43 4.0k 4.0× 301 0.3× 393 0.6× 222 0.4× 136 0.4× 176 7.4k
Yanyan Zhang China 29 907 0.9× 263 0.3× 507 0.8× 454 0.8× 138 0.4× 126 2.4k
Viktor Brovkovych United States 29 838 0.8× 395 0.4× 174 0.3× 418 0.8× 183 0.5× 48 2.6k

Countries citing papers authored by Fakhri Mahdi

Since Specialization
Citations

This map shows the geographic impact of Fakhri Mahdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fakhri Mahdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fakhri Mahdi more than expected).

Fields of papers citing papers by Fakhri Mahdi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fakhri Mahdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fakhri Mahdi. The network helps show where Fakhri Mahdi may publish in the future.

Co-authorship network of co-authors of Fakhri Mahdi

This figure shows the co-authorship network connecting the top 25 collaborators of Fakhri Mahdi. A scholar is included among the top collaborators of Fakhri Mahdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fakhri Mahdi. Fakhri Mahdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shariat‐Madar, Zia, et al.. (2025). Distinct Roles of Common Genetic Variants and Their Contributions to Diabetes: MODY and Uncontrolled T2DM. Biomolecules. 15(3). 414–414. 4 indexed citations
2.
Shariat‐Madar, Zia & Fakhri Mahdi. (2025). Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus. Molecules. 30(22). 4448–4448.
3.
4.
Pomin, Vitor H., Fakhri Mahdi, Weihua Jin, et al.. (2021). Red Algal Sulfated Galactan Binds and Protects Neural Cells from HIV-1 gp120 and Tat. Pharmaceuticals. 14(8). 714–714. 7 indexed citations
5.
Mohammed, Salahuddin, Fakhri Mahdi, Nicholas S. Akins, et al.. (2021). Allopregnanolone and neuroHIV: Potential benefits of neuroendocrine modulation in the era of antiretroviral therapy. Journal of Neuroendocrinology. 34(2). e13047–e13047. 5 indexed citations
6.
Mohammed, Salahuddin, Fakhri Mahdi, & Jason J. Paris. (2020). HIV-1 Tat Dysregulates the Hypothalamic-Pituitary-Adrenal Stress Axis and Potentiates Oxycodone-Mediated Psychomotor and Anxiety-Like Behavior of Male Mice. International Journal of Molecular Sciences. 21(21). 8212–8212. 16 indexed citations
7.
Engel, Jason, et al.. (2019). Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization. American Journal of Physiology-Renal Physiology. 316(5). F1016–F1025. 18 indexed citations
8.
Mahdi, Fakhri, Alejandro Chade, & Gene L. Bidwell. (2019). Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer. Pharmaceutics. 11(10). 542–542. 14 indexed citations
9.
Mahdi, Fakhri, et al.. (2018). Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide. Scientific Reports. 8(1). 7923–7923. 48 indexed citations
10.
Chade, Alejandro, et al.. (2017). Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease. Kidney International. 93(4). 842–854. 32 indexed citations
11.
Bidwell, Gene L., et al.. (2016). A kidney-selective biopolymer for targeted drug delivery. American Journal of Physiology-Renal Physiology. 312(1). F54–F64. 61 indexed citations
12.
George, Eric M., et al.. (2015). Corneal Penetrating Elastin-Like Polypeptide Carriers. Journal of Ocular Pharmacology and Therapeutics. 32(3). 163–171. 12 indexed citations
13.
George, Eric M., et al.. (2015). Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis. PubMed. 7(1). 1–1. 33 indexed citations
14.
Bae, Jung‐Eun, Manal A. Nael, Patrick T.J. Hwang, et al.. (2014). Quinone propionic acid‐based redox‐triggered polymer nanoparticles for drug delivery: Computational analysis and in vitro evaluation. Journal of Applied Polymer Science. 131(13). 7 indexed citations
15.
Matafonov, Anton, Hassan Madkhali, Fakhri Mahdi, et al.. (2014). Prolylcarboxypeptidase Independently Activates Plasma Prekallikrein (Fletcher Factor). Current Molecular Medicine. 14(9). 1173–1185. 16 indexed citations
16.
Mahdi, Fakhri, Miriam Falkenberg, Efstathia Ioannou, et al.. (2010). Thyrsiferol inhibits mitochondrial respiration and HIF-1 activation. Phytochemistry Letters. 4(2). 75–78. 15 indexed citations
17.
Ngo, My‐Linh, Fakhri Mahdi, Dhaval Kolte, & Zia Shariat‐Madar. (2009). Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation. Journal of Inflammation. 6(1). 3–3. 26 indexed citations
18.
Shariat‐Madar, Zia, Fakhri Mahdi, & Alvin H. Schmaier. (2004). Recombinant prolylcarboxypeptidase activates plasma prekallikrein. Blood. 103(12). 4554–4561. 99 indexed citations
19.
Laudes, Ines J., Markus Huber‐Lang, Ren-Feng Guo, et al.. (2002). Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells. The Journal of Immunology. 169(10). 5962–5970. 152 indexed citations
20.
Shariat‐Madar, Zia, Fakhri Mahdi, & Alvin H. Schmaier. (1999). Mapping Binding Domains of Kininogens on Endothelial Cell Cytokeratin 1. Journal of Biological Chemistry. 274(11). 7137–7145. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Holinstat Breakdown of academic impact, for papers by Carol Dangelmaier Breakdown of academic impact, for papers by Noboru Fukuda Breakdown of academic impact, for papers by Vijay K. Kalra Breakdown of academic impact, for papers by Osamu Nakajima Breakdown of academic impact, for papers by S Lévy-Toledano Breakdown of academic impact, for papers by Ingeborg Hers Breakdown of academic impact, for papers by Hanna Mandel Breakdown of academic impact, for papers by Yanyan Zhang Breakdown of academic impact, for papers by Viktor Brovkovych
Rankless by CCL
2026